News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

UCB Japan Co., Ltd. Obtains FDA Approval Of Treatment Drug For Epilepsy Patients



8/14/2006 1:26:42 PM

UCB Japan, a leading global biopharmaceutical company has obtained the approval of Keppra - generic name levetiracetam - 500mg/5mL (100mg/mL) from the U.S. Food and Drug Administration (FDA) for use as an adjunctive therapy for treatment of partial-onset seizures in adults with epilepsy.

Read at JCN Newswire


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES